Renaud Capdeville

26.0k citations
52 papers · 13.0k indexed · 6 hit papers · h-index 29

Renaud Capdeville

51 papers receiving 12.5k citations

Hit Papers

Hematologic and Cytogenetic Responses to Imatinib Mesylat...1.5k199820262007201610002.0k3.0k

Peers

Renaud Capdeville
Comparison fields: 5 of 130
  • Hematology 6.8k
  • Genetics 5.0k
  • Gastroenterology 1.6k
  • Rheumatology 3.3k
  • Oncology 2.8k
Replace Nicholas Lydon with:
Nicholas Lydon Switzerland
Elisabeth Buchdunger Switzerland
Debra Resta United States
Michael W. Deininger United States
Ian W. Flinn United States
Junia V. Melo United Kingdom
Jonathan A. Fletcher United States
Christian Buske Germany
Animesh Pardanani United States
Sandra Silberman United States
Renaud Capdeville relative to Nicholas Lydon Switzerland Nicholas Lydon's profile →
Citations per field
00.5×1.7×
Nicholas Lydon · 1×
Citations per year

Countries citing papers authored by Renaud Capdeville

Since Specialization
Citations

This map shows the geographic impact of Renaud Capdeville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renaud Capdeville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renaud Capdeville more than expected).

Fields of papers citing papers by Renaud Capdeville

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renaud Capdeville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renaud Capdeville. The network helps show where Renaud Capdeville may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Renaud Capdeville, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Renaud Capdeville Line = papers co-authored together Renaud Capdeville links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 2018113
2 201521
3 200812
4 200645
5 2005105
6 200445
7 2004126
8 200421
9 200322
10 2003125
11
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemiabreakdown →
20021517
12 200228
13 200212
14
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia: Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lympoblastic leukemia with the philadelphia chromosome
20019
15 200159
16
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosomebreakdown →
20012070
17
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemiabreakdown →
20013811
18
The polyamine synthesis inhibitor SAM486A in combination with 5-FU/LV in metastatic colorectal cancer (MCC): results of a phase I and pharmacokinetic study
20000
19 200019
20 199792

About Renaud Capdeville

Renaud Capdeville is a scholar working on Hematology, Genetics and Rheumatology, having authored 52 papers that have together received 13.0k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (29 papers), Chronic Lymphocytic Leukemia Research (21 papers), Eosinophilic Disorders and Syndromes (16 papers), Gastrointestinal Tumor Research and Treatment (5 papers), Mast cells and histamine (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Kidney Stones and Urolithiasis Treatments (3 papers). The work is most often cited by research in Hematology (6.8k citations), Genetics (5.0k citations) and Gastroenterology (1.6k citations). Renaud Capdeville has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Brian Druker, Charles L. Sawyers, Debra Resta, Moshe Talpaz, J. Ford, Elisabeth Buchdunger, Hagop M. Kantarjian, Bin Peng, Nicholas Lydon and Sayuri Ohno-Jones. Their work appears in journals such as Blood, New England Journal of Medicine, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and Seminars in Hematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026